Life Scientist > Health & Medical

First adult stem cells from Friedreich's Ataxia patients give hope for new treatment

14 January, 2011 by Tim Dean

Researchers at the Monash Institute of Medical Research (MIMR) and the University of Melbourne have for the first time created adult induced pluripotent stem cells from patients with the rare genetic disorder, Friedreich's Ataxia.


Feature: Immune paradox

05 January, 2011 by Fiona Wylie

Why is it that some HIV patients treated with antiretrovirals end up suffering from a new immunopathology? Martyn French is trying to solve this puzzling conundrum.


Feature: Cancer is a lean, mean, epigenetics machine

29 December, 2010 by Graeme O'Neill

Susan Clark’s team at the Garvan Institute is revealing the complex epigenetic mechanisms that allow various cancers to stifle cellular defences.


Researchers lift the lid on placebos

24 December, 2010 by David Binning

Of course even the most disappointing research student understands that the key to successfully conducting placebo-based studies is keeping your subjects in the dark.


Dairy-derived acids shown to ward off Type 2 diabetes

24 December, 2010 by Staff Writers

Researchers at Harvard University have published a study showing that a group of fatty acids called trans-palmitoleate appears to be connected with decreased risk of Type 2 Diabetes.


Malaria down but not out (yet)

17 December, 2010 by Tim Dean

The WHO report on malaria shows promising reductions in infections and deaths, but scientists warn malaria might be back with a vengeance unless efforts to eradicate it aren't maintained.


Feature: Antibody attack on acute myeloid leukaemia

16 December, 2010 by Staff Writers

CLS Principal Scientist, Samantha Busfield, is working on CSL’s newly developed anti-interleukin-3 (IL3) receptor antibody in the hope that it will provide a new treatment for acute myeloid leukaemia.


LCT gets green light from Russia for Type 1 diabetes treatment Diabecell

10 December, 2010 by David Binning

Living Cell Technologies (LCT) announced today that Russia has become the first country in the world to approve the use and sale of its Diabecell porcine implant for Type 1 diabetics.


Could aspirin help to prevent deaths from cancer, or even cancer itself?

07 December, 2010 by David Binning

British researchers have published the results of a study which shows that a small dose of aspirin daily could dramatically reduce incidences of cancer related death.


New class of HIV drug in the offing

02 December, 2010 by David Binning

Australian biotech Biotron has reaffirmed its commitment to its HIV drug program following the release of an independent international study demonstrating that the protein Vpu plays a key role in allowing the virus to proliferate.


Feature: Puzzling prions

29 November, 2010 by Fiona Wylie

Prions, which cause diseases such as Creutzfeldt-Jakob and bovine spongiform encephalopathy (BSE), are mysterious things. Andrew Hill’s research into how they spread might lead to new diagnostics and treatments.


Avexa to discuss HIV drug with FDA

27 November, 2010 by David Binning

Beleaguered Australian HIV drug developer Avexa announced this week that it has booked time with the FDA to discuss opportunities for its ATC (apricitibane) program.


Universal flu vaccine in the offing

24 November, 2010 by David Binning

Canberra-based biotech Gamma Vaccines reported today that it is ready to start human clinical trials of a universal flu vaccine which it hopes will one day do away with the need for new vaccines to be produced every year while being effective against any pandemic strains.


Infectious diseases targeted by new ithree institute

24 November, 2010 by Staff Writers

The University of Technology Sydney has launched the ithree institute, focusing on the understanding and control of infectious diseases in humans and animals.


Erectile dysfunction linked to higher risk of heart disease

24 November, 2010 by Staff Writers

A team of international researchers has published the results of a study showing a connection between erectile dysfunction and increased risk of heart disease.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd